Skip to content

Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown

CompletedNot applicableNCT04466605
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Covid-19 outbreak and lockdown measures raised significant concerns over clinical management of chronic pain patients around the world. Patients with chronic musculoskeletal pain (CMSP) are at high risk of physical disability, psychological distress, and poor quality of life. Analgesic medications were main management during lockdown, but opioid-related concerns have prompted to find immediate alternatives. Present study was undertaken to determine whether patients randomized to tele-yoga therapy would experience less pain, disability and improved global health, adherence and satisfaction, compared with patients assigned to usual care.

Study details

Official title
Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown: Randomized Clinical Trial
Interventions
  • Other: Tele-yoga therapy
  • Other: Primary care
Sponsor
Aarogyam UK
Collaborators
NMP Medical Research Institute; Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University
Start date
2020-03-30
Primary completion
2020-06-30
Sex
All
Age range
from 18 Years to 60 Years
Results posted
No results posted in this snapshot
Countries
India
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients having pain that was musculoskeletal, defined as regional (joints, limbs, back, neck) or more generalized (fibromyalgia or chronic widespread pain); * Persistent pain ( ≥3 months) despite trying conventional treatment. * Access to virtual platform with internet. * Ready to give informed consent Exclusion Criteria: * Schizophrenia, * Psychiatric disorder * Cognitive impairment * Suicidal ideation * Current illicit drug use * Terminal illness

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04466605